Bristol-Myers Squibb
Also: 1Drop's portable diagnostics tackle the final frontier; AT&T, partners look to streamline patient check-in.
The Boston-based company has now raised a hair over $90 million for its AI pathology platform.
Pharma companies also continued to explore the promises of digital therapeutics.
The pharma company will gain access to Concerto Health's eurekaHealth, an AI and machine learning platform.